About the job
Join Dexis Consulting Group, a vibrant professional services firm committed to collaborating with government and community leaders both domestically and internationally to drive impactful social change in an ever-evolving landscape.
At Dexis, our corporate culture is defined by inclusiveness, respect, fairness, and trust. We empower our employees with the resources and mentorship necessary for success, and we celebrate creativity and innovation.
LEAP Program Overview
Global Solutions Ventures (GSV), a collaborative partnership between ZemiTek, LLC and Dexis Consulting Group, is executing the Long-term Exceptional Technical Assistance Project (LEAP Global), initially established by USAID to combat infectious diseases like malaria, HIV/AIDS, tuberculosis, neglected tropical diseases, and pandemic influenza. As of July 1, 2025, LEAP Global transitioned to the U.S. Department of State (DOS). This initiative is designed to tackle the intricate human resource challenges that national infectious disease programs face in countries supported by the USA.
This project focuses on embedding technical advisors and subject matter experts within governmental entities. By integrating expertise directly into national programs, LEAP Global offers sustainable, lifesaving support that empowers host governments to effectively manage vital aspects of their infectious disease portfolios while enhancing collaboration between the U.S. Government and the host nation.
Position Overview
In alignment with the Trump Administration’s America First Global Health Strategy, the U.S. is dedicated to safeguarding its citizens from global infectious disease threats while aiding partner nations in achieving enduring self-reliance and health sustainability. This strategy prioritizes country ownership, co-investment, the transition of U.S.-supported services to national systems, enhanced public financial management, and the establishment of clear performance benchmarks.
As a priority partner, Angola faces significant challenges with malaria and HIV, which are critical contributors to morbidity and mortality. Strengthening Angola’s capacity to prevent, detect, and respond to these and other epidemic-prone diseases is essential for both the health of Angolans and the security of U.S. health interests.